Impact of cleaning and other interventions on the reduction of hospital-acquired Clostridium difficile infections in two hospitals in England assessed using a breakpoint model

Journal of Hospital Infection

Volumn 84, Issue 3, 2013, Pages 227-234

  Hughes, G J ^a   Nickerson, E ^b   Enoch, D A ^c   Ahluwalia, J ^b   Wilkinson, C ^c   Ayers, R ^b   Brown, N M ^a,b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c PETERBOROUGH CITY HOSPITAL   (United Kingdom)

Author keywords

Clostridium difficile; Disinfection; Infection control Interventions; Nosocomial infection; Statistical model

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CLEANING; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISINFECTION; HAND WASHING; HUMAN; INCIDENCE; INFECTION CONTROL; ISOLATION PROCEDURE; MAJOR CLINICAL STUDY; PROCESS CONTROL; UNITED KINGDOM;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DISINFECTION; ENGLAND; HEALTH SERVICES RESEARCH; HOSPITALS; HOUSEKEEPING, HOSPITAL; HUMANS; MODELS, STATISTICAL;

EID: 84879783330     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.12.018     Document Type: Article

References (34)

1. Karas J.A., Enoch D.A., Aliyu S.H. Areview of mortality due to Clostridium difficile infection. JInfect 2010, 61:1-8.
2. Department of Health, Health Protection Agency Clostridium difficile infection: how to deal with the problem 2009, Department of Health, London.
3. Duerden B.I. Contribution of a government target to controlling Clostridium difficile in the NHS in England. Anaerobe 2011, 17:175-179.
4. Viswanathan V., Mallozzi M., Vedantam G. Clostridium difficile infection: an overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes 2010, 1:234-242.
5. Stoddart B., Wilcox M.H. Clostridium difficile. Curr Opin Infect Dis 2002, 15:513-518.
6. Owens R.C., Donskey C.J., Gaynes R.P., Loo V.G., Muto C.A. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008, 46(Suppl. 1):S19-S31.
7. Kaatz G.W., Gitlin S.D., Schaberg D.R., et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988, 127:1289-1294.
8. McFarland L.V., Mulligan M.E., Kwok R.Y., Stamm W.E. Nosocomial acquisition of Clostridium difficile infection. NEngl J Med 1989, 320:204-210.
9. Pittet D., Allegranzi B., Sax H., et al. Evidence-based model for hand transmission during patient care and the role of improved practices. Lancet Infect Dis 2006, 6:641-652.
10. Dubberke E.R., Reske K.A., Noble-Wang J., et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007, 35:315-318.
11. Dancer S.J. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. JHosp Infect 2004, 56:10-15.
12. Dancer S.J., White L.F., Lamb J., Girvan E.K., Robertson C. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med 2009, 7:28.
13. Mulvey D., Redding P., Robertson C., et al. Finding a benchmark for monitoring hospital cleanliness. JHosp Infect 2011, 77:25-30.
14. Hardy K.J., Gossain S., Thomlinson D., Pillay D.G., Hawkey P.M. Reducing Clostridium difficile through early identification of clusters and the use of a standardised set of interventions. JHosp Infect 2010, 75:277-281.
15. Gran J.M., Iversen B., Hungnes O., Aalen O.O. Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004. Epidemiol Infect 2010, 138:1559-1568.
16. Wagner A.K., Soumerai S.B., Zhang F., Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication using research. JClin Pharm Therapeut 2002, 27:299-309.
17. Zeileis A., Leisch F., Hornik K., Kleiber C. Strucchange: an R package for testing for structural change in linear regression models. JStat Softw 2002, 7:1-38.
18. Carey R.G. Improving healthcare with control charts: basic and advanced SPC methods and case studies 2003, ASQ Quality Press, Milwaukee.
19. Zeileis A., Kleiber C., Krämer W., Hornik K. Testing and dating of structural changes in practice. Comput Stat Data Analy 2003, 44:109-123.
20. Scrucca L. qcc: an R package for quality control charting and statistical process control. RNews 2004, 4:11-17.
21. Stone S.P., Cooper B.S., Kibbler C.C., et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. JAntimicrob Chemother 2007, 59:833-840.
22. Harris A.D., Lautenbach E., Perencevich E. Asystematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis 2005, 41:77-82.
23. Gerding D.N., Muto C.A., Owens R.C. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008, 46:S43-S49.
24. Dumford D.M., Nerandzic M.M., Eckstein B.C., Donskey C.J. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control 2009, 37:15-19.
25. Sethi A.K., Al-Nassir W.N., Nerandzic M.M., Bobulsky G.S., Donskey C.J. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C.difficile infection. Infect Control Hosp Epidemiol 2010, 31:21-27.
26. Best E.L., Fawley W.N., Parnell P., Wilcox M.H. The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis 2010, 50:1450-1457.
27. Boyce J.M., Havill N.L., Otter J.A., et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 2008, 29:723-729.
28. Shapey S., Machin K., Levi K., Boswell T.C. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards. JHosp Infect 2008, 70:136-141.
29. Barbut F., Menuet D., Verachten M., Girou E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 2009, 30:507-514.
30. Falagas M.E., Thomaidis P.C., Kotsantis I.K., Sgouros K., Samonis G., Karageorgopoulos D.E. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. JHosp Infect 2011, 78:171-177.
31. Fowler S., Webber A., Cooper B.S., et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. JAntimicrob Chemother 2007, 59:990-995.
32. Nathwani D., Sneddon J., Malcolm W., et al. Scottish Antimicrobial Prescribing Group. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents 2011, 38:16-26.
33. Talpaert M.J., Gopal Rao G., Cooper B.S., Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. JAntimicrob Chemother 2011, 66:2168-2174.
34. Ludlam H., Brown N., Sule O., Redpath C., Coni N., Owen G. An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea. Age Ageing 1999, 28:578-580.